Home / Inspections / 1247294

FDA Inspection 1247294 — AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP — FEI 2518137

The FDA completed an inspection of AstraZeneca Pharmaceuticals LP on October 4, 2024 in Wilmington, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 4, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Wilmington, DE (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1219696 (NAI Wed Sep 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 930780 (NAI Fri Jun 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895234 (NAI Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 873394 (NAI Mon Apr 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 827010 (NAI Fri Apr 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources